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Abstract 
 
Background:  Several acute and chronic diseases disposes for myocardial oedema and fibrosis, 
leading to impaired cardiac function, presumably as a result of an increased chamber stiffness.  
Mechanisms and adverse effects of both oedema and fibrosis in the heart have only partly been 
elucidated; however, the temporal and spatial development is still unknown. 
 Objective:  The purpose of our study was to: (1) establish an in vivo pulmonary artery (PA) banded 
model that produces myocardial oedema and fibrosis in both ventricles, and (2) examine the temporal 
and spatial development of oedema- and subsequent fibrosis formation in both acute and chronic 
protocols.   
Methods:  A PA-banded model was utilized to elevate the right ventricular (RV) pressure, to 
subsequently produce both right- and left sided ventricular myocardial oedema and on a longer time 
scale, fibrosis, in male Wistar rats.  The left ventricular (LV) oedema formed due to the drainage 
system via sinus venosus and the thebesian veins, further exacerbated by lymphatic congestion, 
allowed us to study the LV itself without interferences from manipulation.  Gravimetric wet to dry 
weight ratio as an index of total tissue water (TTW) and oedema, and hydroxyproline as an indicator 
of total collagen synthesis and fibrosis formation, were measured in the RV and LV and the septum. 
Results:  Right ventricular developed pressure (RVDP) was significantly elevated in all PA-banded 
procedures as compared the initial pressure measurements pre-PA-banding and the corresponding 
sham values.  Contraction (dP/dt maximum) and relaxation (dP/dt minimum) of the RV pressure was 
increased in both acute and chronic experimental PA-banded groups, while heart rate (HR) remained 
unchanged.  No significant increases in TTW or total collagen content was seen until 17 days post-PA-
banding (note: n=1 in each group).   
Conclusions:  Continuously increased RV pressures post-PA-banding demonstrated a marked 
response to the constriction.  The heart seemed to overcome the elevated pressure by increasing 
cardiac contraction and relaxation (dP/dt).  No indication of myocardial oedema or fibrosis formation 
was seen within the first hour of acute PA-banding.  Preliminary data from chronic protocols indicated 
that myocardial oedema was not developed within 24 hours, but after 17 days post-PA-banding, with 
subsequent increases in collagen synthesis (note: n=1 in each group). 
  
1 Introduction 
1.1 Background 
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels.  
CVDs are the number one cause of death worldwide, with an estimate of 17 million deaths 
every year, representing 30% of all global deaths (1, 2).  The annual number of deaths from 
the global epidemic of CVDs is not only increasing, but also shifting from developed to 
developing nations (3).  By 2030, numbers are expected to increase towards 24.2 million 
deaths, a total of 32.5% of all deaths (3).  Norway is a well developed western European 
country with both high life expectancy and standard of living.  CVD incidents are however 
high, accounting for as much as 35% of all deaths in 2007 (4).   
A number of acute and chronic CVDs, such as pulmonary hypertension, chronic pulmonary 
hypertension with right heart failure, chronic arterial hypertension, cardioplegic arrest, 
coronary sinus hypertension and myocardial ischemia predisposes for myocardial oedema, i.e. 
excess of interstitial water, which is associated with impaired heart function (5-10).  Chamber 
stiffness, possibly due to the excess interstitial water and decreased ventricular compliance, 
seems to be an important contributor to the compromised cardiac performance (11).  It has 
been suggested that oedema formation is a trigger for interstitial fibrosis, i.e. altered 
interstitial matrix, resulting in an even stiffer myocardium (12), that will further impair 
cardiac function (13).  Collagen, the most abundant constituent of the interstitial matrix, is an 
important marker of fibrosis formation (13).   
A disease situation highly disposed for myocardial oedema and fibrosis formation can be 
simulated in an experimental model of pulmonary artery (PA) banding, in which the right 
ventricular (RV) pressure is increased by surgically reducing the diameter of the PA, i.e. the 
main outgoing artery from the RV (13).  Mechanisms and effects of both myocardial oedema 
and fibrosis have been partly elucidated; however, the temporal- and spatial development of 
oedema- and fibrosis formation in the heart still needs to be revealed.  With a clinical 
application in mind, knowing the time point and the spatial distribution of oedema- and 
fibrosis formation in the in vivo rat model would be important in the process of finding the 
most effective time for therapeutic treatment, in addition to answering how optimal 
administration should be carried out. 
6
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1.2 The Normal Interstitium 
Interstitial, meaning “in between”, refers to the spaces between the capillary wall and the 
cells.  About one-sixth of the body volume is comprised by the interstitial spaces, which 
mediates the exchange of oxygen, nutrients and waste products between the vascular system 
and the cells.  All organs have an interstitium and the basic structure is similar in all tissue 
organs, i.e. it is principally organized with the same components.  However, the amount of 
interstitium and also the relative amounts of each structure may differ from organ to organ 
(14).  The following components are regarded as the basic constituents of the interstitial 
structure: 
a) Collagen  
b) Glycosaminoglycans (GAGs) 
c) Salt solution 
d) Proteins derived from plasma 
 
1.2.1 Collagen – The Fibre Framework 
Collagen structures predominantly constitute the interstitial skeleton.  Because collagens are 
tensile elements, their main functional effects are to resist changes in tissue configuration and 
volume.  Collagens also function to exclude proteins, and further, they immobilize the 
glycosaminoglycans (GAGs) of the binding network (15).   
Collagens are a group of proteins sharing structural resemblance.  To date, there are at least 
29 known types (16), divided into several subtypes that are widely expressed throughout the 
organs and tissues.  Collagen molecules are arranged into triple helices.  The individual α-
chains are left-handed coiled polypeptide chains, each containing ~1000 amino acids, with 
approximately three residues per turn, every third being glycine (17).  Mainly hydroxyproline 
and proline make up the remaining amino acids in the triplet (17).  Three chains are coiled 
into a right-handed superhelix that is stabilized by hydrogen bonds (interpeptide hydrogen 
bonding) (17).   
Fibril- and subsequent fibre assembly of the collagen molecules are localized to the 
extracellular space.  Collagen is originally synthesized by fibroblast cells that secrete 
procollagen, a precursor molecule, which has both NH2- and COOH- terminal non-triple 
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helical extensions (18, 19).  Procollagen is further modified post-translational to give 
differences in hydroxylation and glucosylation (20).  Peptides originating from part of the 
COOH- and NH2-terminal cleaved during the post-translational modification act as cellular 
feedback regulator for the synthesis (21).  
 
1.2.2 Glycosaminoglycans (GAGs) – The Gel Phase 
Glycosaminoglycans (GAGs) constitute a main importance of interstitial fluid volume control.  
They are generally described as linear polymers of disaccharide repeat units consisting of 
hexosamine and hexuronic acid (22).  GAGs are specifically characterized by their content 
and distribution of charged anionic groups: the carboxylate group (―COO⁻), sulphate ester 
group (―O―SO₃⁻) and sulphamino group (―N― SO₃⁻) that are fully ionized under 
physiological conditions (22).  The osmotic pressure of GAG solutions is partly or wholly due 
to a high negative charge density, producing counter ion attraction and a Donnan distribution 
of diffusible ion density, which refers to the distribution of ion species between two ionic 
solutions separated by a semipermeable membrane, i.e. the vascular wall.  Based on structural 
similarities, four main GAG families are currently known (23).  Subfamilies are differentiated 
by the different composition of the disaccharide units and the possible positions of 
substituents (23).  Most GAGs are sulphated and found covalently attached as side branches 
to a protein backbone to form large, brush-shaped proteoglycans (15).  However, their major 
component hyaluronan, is non-sulphated and found as free polymers in vivo, structurally 
unbranched (essentially linear) with a quaternary structure of random coil (15).  GAG 
molecules do not seem to have particularly strong chemical bindings to each other, but show a 
marked internal entanglement at concentrations >0.1% for hyaluronan and >1% for 
proteoglycans.  At these concentrations, they seem to form a continuous network, possessing 
a gel-like appearance (15).   
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1.2.3 The Fluid Compartment 
The interstitial fluid compartment is comprised of a salt solution and proteins derived from 
plasma.  
Total body water in an average adult human accounts approximately for 60% of the body 
weight.  This is distributed between the intracellular and extracellular compartments, 40- and 
20%, respectively (24).  Interstitial fluid makes up more than three fourths of the extracellular 
fluid, and the remaining one fourth is found in the plasma (24).   
Interstitial proteins are the same proteins that are found in the plasma compartment, because 
of the permeability characteristics of the capillary wall.  Water and electrolytes passes, 
however, much more readily than does plasma proteins, giving the ultrafiltrate a reduced 
protein content.  The interstitial protein concentration is consequently a function of the 
selectivity of the capillary barrier and the transcapillary fluid flux (14, 25).  In the present 
context, the important property of the interstitial proteins is their colloid osmotic pressure, 
contributing to the fluid balance by exerting an interstitial suction force. 
 
1.2.4 Transendothelial Transport 
Transport across the capillary wall is determined by three important factors: 
1. The properties of the capillary membrane 
2. The transcapillary hydrostatic pressures 
3. The transcapillary osmotic pressures 
 
Capillary blood pressure, i.e. the hydrostatic pressure, is the primary force driving 
ultrafiltration.  Filtration is however opposed by the osmotic pressure of the plasma proteins, 
which exerts the only absorptive force.  Ernest H. Starling described this relationship in 1896, 
stating that the net capillary filtration will be zero when the transcapillary hydrostatic pressure 
difference equals the net effective protein osmotic transcapillary pressure (26).  Today, the 
forces and factors determining the transcapillary fluid flux are often referred to as the Starling 
forces, which are summarized in the Starling equation (Formula 1): 
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Jv = LpS[(Pc – Pi) – σ(COPp – COPi)] 
Formula 1.  The Starling equation.  Jv equals the transcapillary fluid flux.  Lp denotes the 
hydraulic conductance and S the surface area of the capillary wall.  P and COP are hydrostatic and 
colloid osmotic pressures, and subscrips c, p and i denote capillary, plasma and interstitial, 
respectively.  σ is the reflection coefficient.   
 
In addition to the forces exerted, filtration highly depends on the capillary filtration 
coefficient (CFC), namely the product of the hydraulic conductance (Lp) and the surface area 
of the capillary wall (S).  The reflection coefficient (σ) is defined as the ratio of the observed 
to theoretical colloid osmotic pressure across the membrane, which denotes the degree of 
protein leakage across a semipermeable membrane (25).  An illustration of the interplay 
between the various factors determining fluid exchange is shown below (Figure 1). 
 
Figure 1.  Schematic overview of the normal interstitial space including its most important 
constituents and the transcapillary interstitial fluid exchange system.  The interstitial skeleton 
is mainly made up by collagen bundles. Proteoglycans represents the multiple sulphated 
glycosaminoglycan (GAG) chains, anchored to a linear core protein, whereas the long hyaluronans 
represent the non-sulphated GAGs, both having a high negative-charge density that is partly or 
wholly responsible for the osmotic pressure.  Transcapillary fluid exchange is determined by the 
forces exerted by the capillary and the interstitium (27).   
INTRODUCTION 
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1.3 Oedema Formation 
The interstitial volume is to a large extent self-adjusting, due to the interplay of a number of 
local automatic mechanisms that functionally act as buffers against extracellular volume 
changes, as described in the next section (Section 1.3.1).  However, when these buffer-
margins of safety are exceeded, oedema becomes apparent.  Oedema is an excess of 
interstitial fluid, in skin normally representing a doubling of interstitial volume, and will 
inevitably develop if the capillary filtration rate exceeds the lymphatic drainage rate for a 
sufficient period of time.  Various causes and conditions leading to oedema formation are 
described in section 1.3.2. 
 
1.3.1 Safety Factors to Prevent Oedema Formation 
Under normal circumstances, i.e. in a steady state, the partition of the total extracellular 
volume (ECV) between plasma and interstitium is governed by the net capillary filtration (JV) 
and lymph flow (JL).  A major factor in volume homeostasis is without doubt lymphatic 
drainage.  Although normal filtration fraction is only ~0.2-0.3% (most tissues), 4-8 litres of 
lymph is produced per day from the more than ~4000 litres of plasma that passes through the 
human microcirculation over the course of day (25).  Interstitial volume is to a large extent 
self-adjusting, due to a number of local automatic mechanisms.  Three consecutive lines of 
defence against oedema development tend to protect the body against fluid accumulation 
during acute insults, as indicated schematically in Figure 2 (28).  The first mechanism of 
defence (I) and probably the most important in everyday orthostasis, is an immediate response 
to increased arterial and/or venous pressure, independent of changes in the interstitial fluid 
volume (IFV).  This response is accounted for by precapillary vasoconstriction (PCC) acting 
through myogenic and/or a local reflex mechanism that will reduce the capillary filtration 
coefficient (CFC) and limit the rise in capillary pressure (Pc) and net filtration transcapillary 
pressure (ΔPtc).  The second line of defence (II), activated by the increase of net capillary 
filtration rate (Jv) and IFV, is accounted for by a rise of interstitial pressure (Pi), dilution of 
interstitial fluid protein and reduction of its colloid osmotic pressure (COPi), and increase of 
local capillary plasma protein concentration and colloid osmotic pressure (COPp).  The third 
line of defence (III) is lymph flow (JL), removing fluid and proteins from the interstitium, that 
will increase in response to a rise in (Pi) (and possibly IFV).  Both mechanism II and III 
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depends on a rise in IFV, and will thus develop more slowly.  Also, only mechanisms II and 
III will be activated in hypoproteinemia, but during a general tendency to oedema formation, 
the washout of proteins from the interstitium, i.e. the reduction in interstitial protein mass, 
will also restore and rise intravascular protein mass to maintain COPp.  
 
 
Figure 2.  Local mechanisms preventing or limiting a rise in interstitial fluid volume (IFV) 
and oedema formation at increased local arterial and/or venous pressure and during 
hypoproteinemia.  Three consecutive lines of defence (I, II and III) may be envisioned.  Red 
arrows indicate oedema-provoking sequences, whereas blue arrows indicate oedema-preventing 
mechanisms.  An increase in the parameter at origin of an arrow will increase (+) or reduce (–) the 
parameter at arrowhead.  PCC, precapillary vasoconstriction; CFC, capillary filtration coefficient; 
Pc, capillary pressure; ΔPtc, net transcapillary filtration pressure; COPp, colloid osmotic pressure of 
capillary plasma; Jv, net capillary filtration rate; IFV, interstitial fluid volume; COPi, colloid 
osmotic pressure of interstitial fluid; Pi, interstitial fluid pressure; JL, lymph flow rate.  [Modified 
from Aukland (28)] 
 
In addition to the self-adjustments of the Starling forces, including local vasomotor reactions, 
and not least the automatic adjustments of the lymph flow, the interstitial structural network 
plays an important role in preventing oedema formation.  A main contributor to this are the 
naturally rigid collagen fibres that resist changes in tissue configuration and volume (15).  
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1.3.2 Oedema Provoking Factors 
The “safety factors” working as buffers against oedema formation described in section 1.3.1, 
may be exceeded in various cases of illnesses, leading to imbalanced Starling forces, in which 
high filtration rates (Jv) or low lymph flow (JL) give rise to tissue swelling.  Capillary pressure 
(Pc) increase is observed in situations of chronically raised venous pressure, seen in e.g. right 
ventricular (RV) heart failure arisen from a clinical course of untreated pulmonary arterial 
hypertension (11).  A fall in plasma colloid osmotic pressure (COPp) can occur in several 
conditions, such as protein loss from e.g. malabsorption, nephrotic syndrome (protein loss 
into urine), or reduced protein synthesis originating from e.g. cirrhosis.  This reduction will 
subsequently raise the capillary filtration rate, and may lead to clinical oedema if the 
concentration falls below ~2g/dL (29).  Oedema is one of the cardinal features of 
inflammation.  Inflammation is associated with endothelial gap formation and increased 
capillary permeability, i.e. hydraulic conductance (Lp) and increased protein permeability, in 
addition to decreased reflection coefficient (σ) (30).  Oedema formation is also enhanced if 
lymph flow (JL) is compromised.  Sun et al. demonstrated that an occlusion of the cardiac 
lymphatic system produced myocardial oedema within hours of such degree that coronary 
capillary compression occurred (31). 
 
1.3.3 The Oedematous Heart 
Myocardial oedema is a common manifestation of many clinical states, and is known for its 
negative impact on cardiac function.  Fluid accumulation has been demonstrated in a number 
of acute and chronic conditions, including cardiac transplantation (32), decreased plasma 
colloid osmotic pressure or myocardial lymph flow impairment during cardioplegia (8, 33), 
altered microvascular permeability by chronic arterial hypertension (34), elevation of 
myocardial microvascular pressures (35), sepsis (36), ischemia (5), pulmonary hypertension 
and right heart disease (6, 7).   
Laine and Allen (7) demonstrated a decreased capability of the heart to maintain cardiac 
output at a constant left atrial pressure as myocardial oedema increased.  Chamber stiffness, 
i.e. end-diastolic pressure-volume relationship, shown to increase with oedema accumulation, 
seems to be an important contributor to this impaired cardiac function, but through a poorly 
understood mechanism (37, 38).  One consequence of increased myocardial stiffness due to 
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excess water is decreased ventricular compliance, which in concert with the accumulated 
water can compromise cardiac ability to contract efficiently (38, 39).  Although interstitial 
collagen has great tensile strength and accounts for a major part of the interstitial structure, 
increased interstitial volume and pressure may displace the collagen fibres or break collagen 
struts loose from their anchoring points (40).  Because contraction relies on a well-organized 
interstitial matrix, a disruption in the collagen structure may compromise cardiac function.  
Additionally, Davis et al. demonstrated that myocardial oedema may be a trigger for 
interstitial fibrosis formation, resulting in increased collagen deposition, also compromising 
cardiac contraction ability (13).  Myocardial oedema as a possible trigger for fibrosis is 
further described in section 1.4.  Figure 3 depicts and summarizes the various factors that 
enhance myocardial dysfunction due to oedema formation. 
 
 
Figure 3.  Mechanisms that potentiate myocardial oedema formation.  Both chronic and acute 
formation of myocardial oedema results in a compromised cardiac function.  If myocardial oedema 
persists chronically, subsequent altered myocardial interstitial matrix or fibrosis formation will 
thus further indirectly depress cardiac function.  CPB, cardiopulmonary bypass; COP, colloid 
osmotic pressure; Pୡ, capillary pressure; CFC, capillary filtration coefficient; CVP, central venous 
pressure.  [Modified from Mehlhorn et al. (10)] 
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Interstitial myocardial oedema is generally associated with left ventricular (LV) dysfunction.  
Even right ventricular (RV) heart failure is associated with LV dysfunction, due to the 
construction and interconnection of the heart ventricles.  In an experimental model of 
pulmonary artery (PA) banding, i.e. surgical reduction of the PA diameter to increase the RV 
pressure, myocardial oedema has been shown to be induced in both the RV and LV.  LV 
becomes oedematous for two reasons.  First, as the PA pressure increases, the right atrial 
(RA) and RV hydrostatic pressures rises.  Pressure subsequently increases in the coronary 
sinus and thebesian veins that drain into the RA from the LV.  The pressure increase disperses 
further through to the LV, resulting in increased trans-microvascular fluid flux and LV 
oedema formation.  Secondly, as cardiac lymph drains into the central venous system, right-
sided pressure elevations (RA, RV, and central-venous pressure) results in a decreased rate of 
removal of excess fluid from the LV via cardiac lymphatics, thus further exacerbating LV 
oedema formation (41, 42).      
 
1.4 The Fibrotic Heart Interstitium 
Regulation of extracellular matrix protein deposition is an important event in many 
physiologic- and pathological situations.  Disturbances of this tightly regulated balance, for 
example by myocardial oedema, as demonstrated by Davis et al. (13), may lead to fibrosis 
development, thus, altering structure, architecture and shape of the heart.  Fibrotic diseases are 
characterized by excessive scarring due to vigorous production, deposition and contraction of 
the extracellular matrix.  Collagen is the main protein in the connective tissue, in which 
excessive deposition is the pathological hallmark of fibrosis.  The fibrotic process occurs over 
time, such as months or years, leading to both diastolic and systolic cardiac dysfunction (43).   
The function of fibrosis is not completely known.  Normally, collagen networks are thought to 
be involved in the transmission of force generated in muscle tissue, acting mechanically in 
synergy with myocytes (12).  Unfortunately, excessive deposition of collagen within the 
myocardium causes a reduced ventricular compliance and cardiac pathology.  With the use of 
Young’s modulus for bending of collagen, MacKenna and co-workers demonstrated, and 
further suggested that the collagen fibres may be major contributors to diastolic stiffness (12).   
Within the heart, transforming growth factor-β1 (TGF-β1), a pro-fibrotic cytokine and a potent 
stimulator of collagen-producing fibroblasts, appears to be one of several factors that mediate 
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fibrosis formation, e.g. Rosenkranz et al. showed this in transgenic mice over-expressing 
TGF-β1 (44).  Angiotensin II (AII) has also been shown to be involved in the regulation of 
myocardial fibrosis (45).  AII seems to be linked to TGF-β1, in which Campbell et al. (46), 
among others, indicated an up-regulation of TGF-β1 by AII in myofibroblasts and cardiac 
fibroblasts.  Proteolytic enzymes, such as matrix metalloproteinases (MMPs) play an 
important role in promoting change and remodelling, and seem to be a large contributor of 
sustaining a dynamic network within the extracellular matrix.  The roles of MMPs and TGF-
β1 in cardiac remodelling may be intertwined.  Increasing evidence point towards an MMP 
regulation by TGF-β1 as demonstrated among others, by Overall et al. (47). 
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1.5 Aims of Study 
Various acute and chronic diseases causes impaired cardiac function as a result of the 
development of myocardial oedema and fibrosis.  The main purpose of this study was to 
establish an experimental model of pulmonary artery (PA) banding, to investigate the 
temporal and potentially spatial distributional development of myocardial oedema- and 
subsequent fibrosis formation in the heart.  By banding the PA, the vessel diameter is reduced, 
resulting in an increased right ventricular (RV) pressure that not only induces myocardial 
oedema and fibrosis in the RV, but also in the left ventricle (LV).  The LV also experiences 
myocardial oedema since thebesian veins and the sinus venosus together drain the RV and the 
LV.  However, since only the RV experiences a pressure overload, the LV is not subjected to 
the subsequent hypertrophy.  This allows us to study the oedemic- and fibrotic effects in the 
LV, independent of the pressure load and hypertrophic effects that are found in the RV.   
 
Within this frame of reference the specific aims were: 
1. Establish an in vivo rat model with PA banding, previously shown by others to induce 
myocardial oedema in both the right and left heart ventricles (7, 13) with subsequent 
fibrosis formation (13). 
 
2. Investigate the temporal and spatial development of myocardial oedema, i.e. 
answering when and where oedema formation takes place, after increasing PA-
pressure in an acute (30-/60 minutes of PA-banding) and chronic (24 hours/17 days 
of PA-banding) experimental situation.  This is determined by using a gravimetric 
wet to dry weight ratio [(Wet weight – Dry weight)/Dry weight)]. 
 
3. Examine the temporal fibrosis formation after increasing PA-pressure.  This is 
demonstrated by a quantitative hydroxyproline determination, further correlated to 
the total collagen content as a fibrotic marker. 
     
  
  
2 Materials and Methods 
 
All procedures were approved by and performed in accordance with regulations from the 
Norwegian Committee for Animal Research (The National Animal Research Authority 
(FOTS) bearing the project id 1222).  The number of animals used was minimized to meet the 
guidelines from the Ethical Committee. 
 
2.1 Animals 
Experiments were performed on 37 adult male Wistar HanTAc:WH rats (Taconic Europe AS, 
Denmark) weighing between 240g and 380g.  Rats were acclimatized for one week before 
experimental procedures, in accordance with Appendix A of the European Convention (ETS 
NO. 123) (48).  Animals were housed in groups of 3 or 4 prior to the experimental procedures 
in ventilated Makrolon IVC Type IV cages (Techniplast Gazzada S.a.r.l., Italy) on soft 
wooden bedding (Scanbur AS Norway, Norway), with 70 air changes/hour.  Rats undergoing 
chronic procedures were, however, allowed to recover individually in separate cages after 
surgery and stored in a Scantainer (Scanbur AS Norway, Norway).  The animals had access to 
water and were fed a standard diet (MR1/Special Diet Service) ad libitum.  Ambient 
temperature in the animal facility was kept within an optimum of 20-21°C, with a relative 
humidity of 40-60% and an artificial light/dark cycle of 12/12 hours.  Health monitoring was 
performed regularly according to the recommendations of Federation of the European 
Laboratory Animal Science Associations (FELASA) (49). 
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2.2 Anaesthesia 
Anaesthesia is inevitable in comprehensive surgical procedures.  It is strictly necessary to 
evaluate the anaesthesia of choice in advance, as some anaesthetics may intervene directly or 
indirectly with your tissue of interest, hence, giving test results with systematic errors.  
Propofol (PropoVet) with fentanyl-fluanisone (Hypnorm) pre-medication was found to 
provide stress-free induction, easily controlled anaesthesia, good analgesia and muscle 
relaxant for the animals during surgery.  This anaesthetic combination has previously been 
shown to provide very stable heart rates, respiration and blood pressures within normotensive 
limits (50), which made it suitable in our rat model of pulmonary artery (PA) banding for 
measuring cardiovascular parameters. 
 
2.2.1 Pre-Anaesthetic Care 
Animals were anesthetized with a bolus dose, 0.5-1.0mL/kg (to effect), of Hypnorm 
intraperitoneally (i.p.) (VetPharma Ltd., UK), containing Fentanyl citrate 0.315mg/mL and 
Fluanisone 10mg/mL.  Hypnorm produced heavy sedation and usually unconsciousness in the 
rats, providing a stress-free environment during the intravenous (i.v.) cannulation of the tail 
vein.  Hypnorm is a neuroleptanalgesic, in which fentanyl is an analgesic of the morphine 
type and fluanisone is a neuroleptic of the butyrophenone group. 
Due to an unfortunate delivery stop from the manufacturer, Hypnorm was temporarily 
unavailable.  Consequently, some animals were anesthetized with a bolus dose of Mebumal 
(pentobarbital, 50mg/kg, Apotek 1 Svanen, Norway).  Mebumal is a short-acting barbiturate 
derivative, normally used as a sedative in circulatory research, and was given in a dosage of 
0.1mL/100g i.p., until anaesthetic level was reached.  Similar to Hypnorm, it also provided 
heavy sedation, giving a less stressful cannulation of the tail vein. 
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2.2.2 Peri-Anaesthetic Care 
PropoVet (propofol, 10mg/mL, Abbott Logistics B.V., Netherlands), given i.v. via the tail 
vein, provided deep anaesthesia during surgery.  Propofol (2,6-diisopropylfenol) is a quick 
acting and short lasting i.v. anaesthetic with a rapid recovery time (50).  It has a depressant 
effect on the central nervous system (CNS), leading to unconsciousness in the animal.  A 
bolus i.v. dose of 0.1mL was useful in deepening the anaesthesia to a level which could be 
easily maintained by a continuous infusion, keeping a flow rate of 3-5mL/kg/h (to effect).  
The appropriate depth of anaesthesia was judged by the absence of eye reflexes and a 
response to paw pinch. 
 
2.2.3 Post-Anaesthetic Care 
Incision area was greased with EMLA cream (AstraZeneca AS, Norway), containing lidocain 
and prilocain, providing local analgesia.  The rats were also treated with 0.05mg/kg s.c. 
Temgesic (Schering-Plough AS, Norway) repeatedly two to three times a day, till three days 
after surgery.  Temgesic is an analgesic with an action time of 8-12 hours, containing 
buprenofinhydrochlorid equivalent to 0.3mg of buprenorphine. 
 
2.2.4 Euthanasia 
The rat heart was fully exposed during the surgical sternotomical procedure.  Methods and 
analyses in later stages of the research required heart samples, so that animal euthanasia was 
performed by excision of the rat heart. 
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2.3 Experimental Setup 
2.3.1 Tail Vein Cannulation and Endotracheal Intubation 
All surgical procedures were performed under aseptic conditions.  Animals were anesthetized 
as described in section 2.2.  Lateral or dorsal tail vein was cannulated using a 24 gauge (G) 
intravenous (i.v.) cannula (Terumo Europe N.V., Leuven, Belgium).  Cannulation was 
prepared by cleansing the tail with warm water on sterile compresses, followed by thoroughly 
drying.  This preparation both further dilated the veins, and more importantly, cleansed and 
softened the skin, facilitating insertion.  The tail veins are located immediately beneath the 
skin, and were thus, entered at a very shallow angle, almost parallel to the vein by slightly 
bending the tail down at the incision area (Figure 4).   
 
 
Figure 4.  Cannulation of the lateral or dorsal tail vein, using a 24G cannula. 
 
The i.v. cannula was connected to a syringe pump (Terumo terfusion syringe pump TE-312, 
Vingmed AS, Norway) to provide a continuous infusion of PropoVet (3-5mL/kg/h), as 
described in section 2.2.  The rats were intubated to prevent the lungs from collapsing during 
the open chested procedure, utilizing the principle of blind oral tracheal intubation as 
described by Stark et al. (51).  An over-the-needle 16G i.v. cannula (Becton Dickinson AB, 
Sweden) was modified to a tube, simply by removing the needle.  Intubation was performed 
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by placing its upper incisors onto a wire construction made on a Plexiglas wall, leaving the rat 
all stretched (Figure 5).  In this way, there was an easy and straight path from the mouth to the 
trachea.  Using a very strong light source onto the throat, shining through the skin, one could 
easily recognize the larynx when the tongue was withdrawn.  The cannula could then be 
placed into the trachea to ventilate the rat.   
 
 
Figure 5.  Intubation of rat in order to provide sufficient ventilation while under open thorax 
surgery.  The pathway to the trachea was more easily recognized by placing the upper incisors 
onto the wire construction while strongly illuminating the throat.  
 
The endotracheal tube was further connected to a mechanical ventilator (TOPO dual mode 
ventilator, Kent Scientific Corporation, USA) set to deliver room air, and adjusted to a 
constant volume ventilation mode set to ~50 breaths per minute and a peak inspiratory 
pressure meter reading a physiologic range between 8 and 12 cmH2O.  Settings were later 
adjusted in accordance with the measured blood gases to meet optimal ventilation for the rat, 
keeping pH values within limits of 7.40-7.44.  To maintain a positive airway pressure 
throughout the expiratory phase during the mechanical ventilation, a positive end expiratory 
pressure (PEEP) was provided, thus keeping alveolar distension, improving pulmonary gas 
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exchange, and not least, preventing pulmonary oedema.  The PEEP was obtained by causing a 
resistance on the exhaust port of the ventilator.  A section of tubing was therefore placed 3.5 
cm under water in a filter flask, creating a PEEP of 3.5 cmH2O (Figure 6).   
 
 
Figure 6.  Positive end expiratory pressure (PEEP) setup.  A filter flask was filled with 3.5cm 
of water above the section tube (A) and connected to the exhaust port of the ventilator (B), to 
create a PEEP of 3.5cmH2O. 
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2.3.2 Surgical Procedure – Pulmonary Artery Banding 
The intubated rat was placed in a supine position onto a water-circulated operation tablet 
(Figure 7), maintaining a core body temperature of 37±1°C.  Temperature was continuously 
controlled with a rectal probe (Figure 7).  Eyes were treated with eye ointment (Simplex 
Øyesalve, Ophtha AS, Denmark) to prevent drying during the surgical procedure.  Further on, 
rat chest was shaved and cleansed with alcohol.   
 
 
Figure 7.  Experimental setup before surgically opening the animals.  Anaesthesia was 
provided through a continuous intravenous (i.v.) infusion via one of the tail veins (A).  
Anesthetized rats were restrained onto an operating tablet (B).  Sufficient ventilation was provided 
through a tracheal intubation connected to a ventilator (C).  A rectal probe continuously controlled 
the body temperature in the animal (D). 
 
The chest was opened by a median sternotomy to reach the heart that was cradled in the 
incised pericardium for stabilization.  Furthermore, the pulmonary artery (PA) was identified 
under the thymus and dissected from the surrounding tissue (Figure 8), followed by passing a 
4-0 silk suture around (Figure 9).  Experimental groups, except sham operated rats, were 
subsequently treated with the following: The suture was tied tightly against a 16G luer stub 
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adapter (Figure 10), which was then quickly removed, leaving only the suture around the PA.  
This procedure produced a PA-constriction of the same diameter in each rat.  
 
 
Figure 8.  Pulmonary artery (PA) dissection from the surrounding tissue.  The heart and PA 
were accessed via median sternotomy.  PA was identified under the thymus and dissected from the 
surrounding tissue, using surgical forceps. 
 
 
Figure 9.  Preparation for pulmonary artery (PA) banding.  A 4-0 silk suture was placed 
around the PA, now ready for banding. 
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Figure 10.  Luer stub adapter.  A 16G luer stub adapter was used to produce a pulmonary artery 
(PA) banding of the same diameter in each rat.  For practical reasons, the small adapter was thread 
onto a suture and knot in both ends of the adapter. 
 
 
To verify the changes in the PA-pressure, right ventricular developed pressure (RVDP) was 
measured (Formula 2).   
 
RVDP = RSP – RDP 
Formula 2.  Definition of right ventricular developed pressure (RVDP).  RSP, Right 
ventricular systolic pressure; RDP, Right ventricular diastolic pressure. 
 
As a PA-catheter is difficult to place in rats, RVDP was measured by placing a 25G i.v. 
cannula (Terumo Europe N.V., Belgium), into the lumen of the right ventricle (RV) (Figure 
11).  The cannula was attached to a fluid-filled pressure transducer (Edwards Lifesciences 
LLC, USA) that was further connected to PowerLab (PowerLab/8SP, ADInstruments Ltd., 
UK) via an amplifier.   
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Figure 11.  Right ventricular (RV) pressure measurement.  The heart was stabilized in a 
pericardial cradle and a 25G i.v. cannula was placed directly into the RV for pressure 
measurement. 
 
Depending on protocol, rats undergoing acute procedures were euthanized while still under 
surgical anaesthesia, whereas rats undergoing chronic procedures were closed thoroughly with 
suture and allowed to recover.  Those animals were treated with post-anaesthetic care, as 
described in section 2.2.3, to provide good analgesia.  Animals were also administrated ~3mL 
of saline infusion s.c. three times a day during the first two days of recovery, in which animals 
may not drink within the first 12-24 hours (52).  Before ending chronic protocols, rats were 
re-anesthetized and sternum re-opened to measure RVDP before the heart was excised.  Sham 
operated rats were subjected to the same surgical protocol without PA-banding. 
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2.3.3 Pressure Measurements and Calibration 
PowerLab is a high-performance data acquisition system, capable of recording at speeds up to 
200 000 samples per second continuously to disk.  Pressure data transferred from the pressure 
transducer via an amplifier, was converted to mmHg using the software Chart5 for Windows 
(ADInstruments Ltd., UK).  Pressure transducer was filled with physiological saline or 
ddH₂O, while the pressure catheter (i.v. cannula) was filled with a 20IE/mL Heparin “lock”.  
Air bubbles in the system that could interfere with measurements were avoided.  A system 
calibration was performed before every pressure measurement, keeping the pressure 
transducer levelled with the heart (Figure 12).   
 
 
Figure 12.  Pressure measurement setup.  A fluid filled pressure transducer (A) was connected 
to a 25G i.v. cannula, used as a pressure catheter (B), placed into the right ventricle of the rat heart 
for pressure measurement. 
 
A mercury manometer was connected to the pressure transducer and inflated to a level of 
200mmHg to calibrate and convert the electric output provided to PowerLab to a level of 
200mmHg (Figure 13).  The system was thereafter exposed to atmospheric pressure where 
output was set to 0mmHg (Figure 13). 
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Figure 13.  Calibration curve as shown on the computer connected to the PowerLab.  A 
mercury manometer was connected to the pressure transducer and inflated to a level of 200mmHg 
to convert the electric output (here: 39.8mV) to 200mmHg.  The system was then exposed to 
atmospheric pressure where output (here: 0.36875mV) was set to 0mmHg.  
 
 
2.3.4 Blood Gases, Hematocrit, Electrolytes and Glucose 
To monitor the physiologic condition in the mechanical ventilated rat, sample sizes of 
~0.05mL blood was withdrawn directly from the right heart ventricle (RV) via the i.v. cannula 
placed for pressure measurement.  Analyses for blood gas variables (pH, pCO2, pO2), 
hematocrit and various electrolytes (Na+, K+, Ca2+, Cl⁻) were performed on a blood gas 
instrument (Radiometer ABL77 Series, Bergman Diagnostika AS, Norway).  Derived values, 
such as haemoglobin, HCO3⁻ and sO2 were also included.  Blood glucose was measured 
utilizing a blood glucose meter (Precision Xceed, MediSense, Abbott Laboratories AS, 
Norway), using disposable test strips (Precision Xtra Plus, Abbott Norge AS, Norway) 
requiring only 0.3µL of blood.  Calibration of the two instruments was regularly performed.   
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2.4 Experimental Setup and Treatment Design 
Two separate experimental groups were studied at various time points: rats subjected to 
pulmonary artery (PA) banding and sham rats that were subjected to the same operative 
procedure, including dissection of the PA, with the sole exception of the placement of the 
band.  Baseline controls (CtrBL) at time 0 were also included to evaluate the basal level of the 
total tissue water (TTW) and collagen content.  An overview of the experimental setup, 
including the number (n) of rats is shown in Table 1. 
 
Table 1.  An overview of the experimental groups.  Number of rats in each group is indicated as 
n in the parentheses.  CtrBL, Control baseline; Sham, sham experimental groups; PA, pulmonary 
artery banded experimental groups.   
Type of 
Procedure 
Treatment 
time 
Experimental groups 
 
CtrBL/sham (n) PA (n) 
Acute 0 minutes 6 
Acute 30 minutes 6 6 
Acute 60 minutes 6 6 
Chronic 24 hours 3 2 
Chronic 17 days 1 1 
 
During acute experiments (30-/60 minutes of PA-banding), heart function, rectal and thoracal 
temperatures, glucose and blood gases were regularly monitored as depicted in Figure 14.  
Heart function variables included right ventricular developed pressure (RVDP), contractility 
index (dP/dt) and heart rate (HR).  RVDP was defined in Formula 2 (section 2.3.2) as the 
right ventricular systolic pressure subtracted by the right ventricular diastolic pressure.  dP/dt 
(delta pressure divided by delta time), meaning the first derivative of the pressure wave with 
respect to time, is regarded as an index of the myocardial contractile state, which gives an 
indication of the rate of rise (dP/dt maximum) and rate of fall (dP/dt minimum) of the right 
ventricular pressure wave.  HR is defined as the number of heart beats per unit time (minutes) 
(BPM).  All monitored variables were reported both pre-PA-banding, i.e. after a pressure 
measurement stabilization period of 10 minutes, and subsequently post-PA-banding, i.e. after 
15- (only heart function variables), 30- and 60 minutes.  Chronic experiments (24 hours/17 
days of PA-banding) were monitored slightly different, however, in a similar manner (Figure 
14).  During surgery, when banding the PA, only temperature variables were monitored.  At 
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re-opening, meaning in the end of the chronic protocol, heart function parameters were 
included in the monitored parameters.  After ending experimental protocols, hearts, lungs and 
biceps femoris muscle were weighed.                                      
ACUTE 
 
   
CHRONIC 
 
Figure 14.  Experimental protocol for acute and chronic procedures.  A stabilization period of 
10 minutes (10’ STAB PRE-PA-BANDING) was allowed before banding the pulmonary artery 
(PA).  Rats were continuously PA-banded from time 0’ until end of experiments.  Crosses indicate 
time points at which blood samples were drawn for blood gas- and glucose analyses, in addition to 
reporting heart function parameters (Right ventricular developed pressure (RVDP), heart rate (HR) 
and the rate of rise (dP/dt maximum) and relaxation (dP/dt minimum) of the right ventricular 
pressures).  CtrBL, Control baseline; Sham, sham experimental groups; PA, PA banded 
experimental groups.  ‘, minutes; h, hours; d, days. 
Pressure measurements, glucose, and blood gases
Pressure measurements
Sham24h 
PA24h 
 
Sham17d 
PA17d 
CtrBL 
Sham30min 
PA30min 
Sham60min 
PA60min 
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2.5 Myocardial Oedema 
Total tissue water (TTW) is a measure of the transcapillary water transport resulting in 
oedema, i.e. the water content in an organ or tissue.  TTW content is comprised of vascular 
water, interstitial water, and cellular water (7).  The amount of myocardial oedema or TTW 
was determined using a gravimetric method, defined as the water content per gram of dry 
tissue weight [(wet weight – dry weight)/(dry weight)].  To identify the amount of myocardial 
oedema accumulation, wet to dry ratios were measured at various time points after pulmonary 
artery (PA) constriction or sham procedures (see section 2.4, Figure 14, for time points).  
Each heart sample was divided into left and right ventricles and the septum.  These were 
further split into basis, mid and apex.  Control samples from the biceps femoris muscle and 
lungs were subsequently collected.  Samples were weighted before drying to obtain wet 
weight, using a highly accurate scale (Mettler Toledo AX 205 DeltaRange, Mettler-Toledo 
AS, Norway) set to “fast” user selection with four digit decimals.  A blood correction was not 
performed due to the small sample size.  Quantification of myocardial oedema was performed 
by utilizing a freeze dryer.  
 
2.5.1 Freeze Drying 
Freeze drying is a dehydration technique, which enables liquid or slurry products, which have 
previously been frozen to be dried under a vacuum.  Samples were therefore initially frozen to 
-80°C as soon as possible after sampling, in such way that the product exhibited the desired 
crystalline structure, and so that it was frozen below its eutectic temperature.  Frozen samples 
were subsequently freeze-dried (VirTis Wizard 2.0 Control System, SP Industries, USA).  In 
order to obtain an end-product of satisfaction, i.e. dry tissue, the partial pressure of the vapour 
surrounding the product must be lower than the pressure of the vapour from the ice at the 
same temperature.  Additionally, the energy supplied in the form of heat must remain lower 
than the eutectic temperature of the product (the highest allowable product temperature during 
the conditions of sublimation).  Condenser and vacuum at low temperature (shelf temperature 
holding at least -20°C) was manually set, during which the sample water sublimated, resulting 
in a dry tissue.  All samples were dried overnight.  To control that the tissue samples were 
sufficiently dry after one overnight freeze drying session, the first sets of samples were 
subsequently dried another night to confirm that the dry weight was not changed.  Vacuum 
MATERIALS AND METHODS 
33 
 
was thereafter released and the dried tissue was allowed to defrost and stabilize at room 
temperature for 20 minutes before weighing (Mettler Toledo AX 205 DeltaRange, Mettler-
Toledo AS, Norway).   
 
2.6 Collagen Content – Hydroxyproline Analysis 
Total collagen was analyzed according to the method described by Woessner (53), based on a 
hydroxyproline colorimetric assay.   
Freeze dried tissue was prepared by hydrolysis without preliminary purification overnight at 
120°C, in sealed test tubes in the presence of HCl.  Content was allowed to reach room 
temperature before rinsing and dilution with ddH₂O to a total volume of 4mL.  Samples were 
subsequently diluted with ddH₂O, volume depending on the amount of freeze dried tissue 
((225/Xmg freeze dried tissue/4mL)) × 5), to reach a total volume of 4.5mL and a final tissue 
concentration of 0.25µg/µL.  
Experimental reagents and standards were prepared as described in Appendix A.  All 
reagents, except p-dimetylamino benzaldehyde (p-DABA), were stored in a refrigerator, but 
allowed to reach room temperature before use.  p-DABA was solved and stored in a water 
bath holding 60±1°C.  As reactions were time dependant, it was important to keep track of 
time during the following analytical procedure.  Hydrolysed samples were pipetted into soft 
plastic test tubes, where Chloramine-T reagent was added.  Twenty minutes later, Perchloric 
acid was added, mixed uniformly in the solution, and left at room temperature for 5 minutes, 
before  p-DABA was added.  After mixing, the tubes were placed in a water bath keeping 
60±1°C, for 20 minutes, before cooled in tap water for 5 minutes to stop the reaction.  Sample 
sizes of 250µL were dispensed in duplicates into microplates with 96 wells (MaxiSorp, 
NUNC, Denmark).  Absorbance was finally read at 557nm using a spectrophotometrical 
microplate reader (Molecular Devices SpectraMax Plus 384, GMI Inc., USA).  Results were 
displayed through a computer (Pentium processor with Windows XP), using the software 
Softmax PRO (Molecular Devices, USA). 
A standard curve was made that correlated with the amount of hydroxyproline in 125 µg of 
the sample tissue.  Total collagen concentration was correlated to hydroxyproline by a factor 
of 6.94 (µg collagen/µg hydroxyproline). 
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2.7 Statistical Analysis 
Values were presented as mean ± standard error of the mean (SEM).  Body-, heart-, lung-, and 
skeletal muscle weights, right ventricular developed pressures (RVDP), heart rates (HR), 
contractility indexes (dP/dt maximum and minimum) of the right ventricular pressures, pH, 
hematocrit, glucose, and total tissue water (TTW) were tested for group differences by one 
way analysis of variance (ANOVA) combined with the Fisher post hoc test by using Minitab 
statistical software (Minitab 15 English.Ink, Minitab Inc., USA).  P<0.05 was considered 
statistically significant. 
 
  
  
3 Results 
The scope of this Master’s thesis was threefold.  Firstly, to establish an in vivo model of 
pulmonary artery (PA) banding, as shown by others (13) to produce myocardial oedema with 
subsequent fibrosis formation.  By reducing the diameter of the PA, the right ventricular 
developed pressure (RVDP) was expected to increase, giving rise to myocardial oedema, 
possibly leading to subsequent fibrosis formation over time.  Hence, heart function variables, 
such as RVDP, right ventricular (RV) contractility and rate of relaxation (dP/dt), and heart 
rate (HR), were monitored to verify the experimental model.  Secondly, sham- and PA-
banded experimental groups were studied to investigate the temporal development of oedema- 
and fibrosis formation in acute and chronic protocols, respectively undergoing 30-/60 minutes 
and 24 hours/17 days of banding.  Thirdly, rat hearts were divided into: (1) RV, left ventricle 
(LV) and septum, and (2) each further into basis, mid and apex, to investigate a possible 
spatial distribution of myocardial oedema and fibrosis formation.   
Acute protocols were represented by 6 animals in each experimental group, whereas chronic 
protocols were represented by only 1-3 animals in each group, making statistical data analysis 
not possible.  Chronic procedures were in total performed on 15 rats.  Four animals treated 
with PA-banding died post-operatively, respectively 2-, 3-, 6- and 8 days post surgery, 
whereas results from three animals (24 hour sham and PA-banded) could not be presented due 
to an accidental incidence regarding handling of test samples.  One sham animal survived 
however longer than 17 days, but did not fit into any of our experimental protocols, hence, not 
presented.  Consequently, analytical data from 7 rats were left to be presented in the chronic 
experimental results.  An extensive surgical procedure, high mortality rate and an accidental 
incidence regarding some tissue samples, combined with the restricted time available for this 
study caused a limited amount of performed experimental protocols and subsequently, a 
limited representation of the experimental data especially from the chronic protocols.   
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3.1  Right Ventricular Developed Pressure (RVDP) 
Right ventricular developed pressure (RVDP) increased significantly after pulmonary artery 
(PA) banding in comparison to the initial pressure measured pre-banding (PA15min 
43±2mmHg vs. PA0min 23±1mmHg, p<0.05) (Figure 15).  By contrast, RVDP values in the 
sham groups did not differ from the initial pressure (Sham15min 29±1mmHg vs. Sham0min 
24±1mmHg, ns).  Furthermore, RVDP was significantly higher in the PA-banded groups as 
compared to the sham groups from 15 minutes of PA constriction and throughout 
experimental protocols (PA15min 43±2mmHg vs. Sham15min 29±1mmHg, p<0.05) (Figure 15).  
However, as chronic protocols were represented by a limited number of animals in the 
experimental groups, data are only to be considered preliminary.  Nevertheless, the 
preliminary data showed a trend of elevated RVDP in the PA-banded experimental groups as 
compared to corresponding shams after 24 hours and 17 days (PA24h 41±0.5mmHg and PA17d 
35mmHg vs. Sham24h 22±0.3mmHg and Sham17d 17mmHg). 
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Figure 15. Right ventricular developed pressure (RVDP) during the acute and chronic 
experimental protocols.  All data points from 15 minutes and onwards in the pulmonary artery 
(PA) banded groups were significantly elevated in comparison to the initial pressure measurement 
pre-PA-banding (0’) and the corresponding sham measurements.  Preliminary data show that the 
RVDP seemed to be elevated still 24 hours and 17 days post-PA-banding as compared to the 
corresponding sham values.  Symbols with error bars represent group means ± SEM.  *p<0.05 vs. 
corresponding sham group; #p<0.05 vs. initial pressure measured pre-PA-banding (0’).  Number 
of observations is indicated above/under each time point, due to a combined representation of the 
two experimental groups in the early phase of acute protocols, until sampling 30- and 60 minutes 
post-banding.  However, acute experimental groups were represented by n=6, whereas chronic 
experimental groups were represented by: Sham24h (n=3); Sham17d (n=1); PA24h (n=2); PA17d 
(n=1).  ‘, minutes; h, hours; d, days. 
Acute       Chronic 
RESULTS 
37 
 
3.2 Right Ventricular Contractility and Rate of 
Relaxation (dP/dt) 
Changes in the right ventricular developed pressure (RVDP) during the experimental period 
were reflected with similar changes in the right ventricular (RV) contractility (dP/dt 
maximum) and rate of relaxation (dP/dt minimum).  dP/dt maximum, i.e. the RV contractility, 
increased significantly following pulmonary artery (PA) banding in the experimental period 
(Figure 16).  dP/dt minimum, i.e. the RV rate of relaxation, paralleled the changes in 
contractility with significant decreases (Figure 16).   
The PA-banded groups showed a significantly increased contractility (dP/dt maximum) from 
15 minutes of banding and onwards, as compared to the initial measurement pre-banding 
(PA15min 1895±140mmHg/s vs. PA0min 1019±83mmHg/s, p<0.05) (Figure 16).  Sham values 
showed, however, no significant changes throughout protocols as compared to the initial 
measurement (Sham15min 1318±86mmHg/s vs. Sham0min 1078±77mmHg/s, ns).  Moreover, 
the contractility of the PA-banded groups were significantly increased as compared to the 
corresponding sham values measured 15 minutes post-banding and onwards (PA15min 
1895±140mmHg/s vs. Sham15min 1318±86mmHg/s, p<0.05) (Figure 16).  Contractility 
reached its maximum at 60 minutes post-PA-banding (PA60min 2708±374mmHg/s), where 
contractility was significantly and approximately increased by ~115% as compared to the 
corresponding sham (Sham60min 1261±104mmHg/s) (Figure 16).  Preliminary data from the 
chronic protocols showed that the increased contractility still seemed to be elevated after 17 
days of banding in the PA-banded protocol as compared to corresponding sham value (PA17d 
1518mmHg/s vs. Sham17d 828mmHg/s) (Figure 16). 
From 15 minutes of banding and onwards, the rate of relaxation (dP/dt minimum) was 
significantly different in the PA-banded groups as compared to the initial value measured pre-
PA-banding (PA15min -1427±117mmHg/s vs. PA0min -700±71mmHg/s, p<0.05), whereas sham 
values remained unchanged (Sham15min -1039±65mmHg/s vs. Sham0min -824±61mmHg/s, ns) 
(Figure 16).  The RV rate of relaxation in the PA-banded groups were also significantly 
different as compared to the corresponding sham values measured from 15 minutes of 
banding and throughout experimental protocols (PA15min -1427±117mmHg/s vs. Sham15min -
1039±65mmHg/s, p<0.05) (Figure 16).  Preliminary data from chronic protocols showed that 
the cardiac relaxation seemed to remain changed still after 17 days of banding in the PA-
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banded protocol as compared to corresponding sham value (PA17d -1233mmHg/s vs. Sham17d 
-532mmHg/s) (Figure 16). 
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Figure 16.  Right ventricular (RV) contractility and relaxation calculated as the first 
derivative of the right ventricular pressure wave (dP/dt).  The pulmonary artery (PA) banded 
groups showed significantly increased contractility (dP/dt maximum) from 15 minutes and 
onwards, as compared to the initial measurement pre-PA-banding and the corresponding 
measurements in the sham groups.  Similarly, the rate of relaxation (dP/dt minimum) was 
significantly different in the PA-banded groups from 15 minutes of banding as compared to the 
initial value of the same group, and as compared to the corresponding sham values.  Symbols with 
error bars represent group means ± SEM.  *p<0.05 vs. corresponding sham group; #p<0.05 vs. 
initial pressure measured pre-PA-banding (0’).  Number of observations is indicated above/under 
each time point, due to a combined representation of the two experimental groups in the early 
phase of acute protocols, until sampling 30- and 60 minutes post-banding.  However, acute 
experimental groups were represented by n=6, whereas chronic experimental groups were 
represented by: Sham24h (n=3); Sham17d (n=1); PA24h (n=2); PA17d (n=1).  ‘, minutes; h, hours; d, 
days. 
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3.3 Heart Rate 
The heart rate (HR) of the pulmonary artery (PA) banded groups of the acute protocols were 
not represented by significance until 60 minutes post-banding as compared to the 
corresponding shams (PA60min 425±13 beats per minute (beats/min) vs. Sham60min 377±17 
beats/min, p<0.05) (Figure 17).  However, no difference was seen between the PA-banded 
value and the initial measured value pre-PA-banding after 60 minutes (PA60min 425±13 
beats/min vs. PA0min 369±21 beats/min, ns) (Figure 17).  Preliminary data from the chronic 
protocols indicated a tendency of a collective and relative HR increase of about ~10-15% as 
compared to the corresponding initial measurements of the acute protocols (Figure 17). 
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Figure 17.  Heart rates (HR) during the acute and chronic experimental protocols.  No 
significant increases in HR were seen until 60 minutes post-banding in the pulmonary artery (PA) 
banded group as compared to the corresponding sham.  However, no significance was seen 
between the PA-banded value 60 minutes post-banding as compared to the initial measurement 
pre-PA-banding.  Preliminary data from the chronic protocols indicated a tendency of a general 
HR increase as compared to the corresponding initial measurements of the acute protocols.  
Symbols with error bars represent group means ± SEM.  *p<0.05 vs. corresponding sham group.  
Number of observations is indicated above/under each time point, due to a combined 
representation of the two experimental groups in the early phase of acute protocols, until sampling 
30- and 60 minutes post-banding.  However, acute experimental groups were represented by n=6, 
whereas chronic experimental groups were represented by: Sham24h (n=3); Sham17d (n=1); PA24h 
(n=2); PA17d (n=1).  ‘, minutes; h, hours; d, days. 
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3.4 Temporal and Spatial Distribution of Oedema in 
the Heart 
In the process of determining the temporal development of myocardial oedema in a 
pulmonary artery (PA) banded rat model, the spatial distribution of the oedema formation was 
subsequently investigated.  The formation of oedema was determined by a quantitative 
increase in the amount of total tissue water (TTW) of the myocardial interstitium.  Right- and 
left ventricles and the septum were divided into basis, mid- and apical areas for the 
investigation of a spatial oedema formation (Figure 18).  A baseline control group (i.e. the 
component concentration level before introducing animals to experimental conditions) was 
additionally included in the protocols to represent the basal level of the TTW. 
 
 
Figure 18.  Illustration of the division of the right- and left heart 
ventricles and septum to determine a possible spatial development of the 
oedema formation in the heart.  Heart ventricles and septum were each 
separated into basis (B), mid (M) and apical (A) sections. 
 
The main overall features of the TTW explored in the gradient sections of the heart ventricles 
revealed no differences within PA-banded groups of the acute protocols, i.e. within the first 
hour of PA-banding, as compared to the baseline control and corresponding shams.  In 
contrast, large increases were seen towards the end of chronic protocols, i.e. after 17 days of 
PA-banding, as compared to the corresponding shams and values from the acute protocols 
(Figure 19).  Nevertheless, the large TTW changes seen after 17 days are only to be 
considered as preliminary, due to the limited number of animals in the experimental groups.     
No significant changes were seen in the PA-banded groups of the acute phase (30-/60 minutes 
of PA-banding) as compared to the corresponding shams and respective baseline values 
(Figure 19).  However, the TTW of the left ventricular (LV) spaces showed general trends of 
reduction as compared to the respective baseline values, with significance only in the sham 
groups of the LVmid after 60 minutes of banding (Sham60min 3.9±0.1 vs. CtrBL 4.5±0.2, p<0.05) 
and the LVapex after 30- and 60 minutes of PA-banding (Sham30min 4.0±0.3 and Sham60min 
3.8±0.1 vs. CtrBL 4.5±0.1, p<0.05) (Figure 19). 
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As chronic protocols (24 hours/17 days of PA-banding) were represented by a limited number 
of animals in the experimental groups, data are only to be considered as preliminary.  The 17 
day protocols that are represented by one animal in each group are, thus, presented without 
SEM values.  The preliminary data showed that all gradient heart sections of the PA-banded 
groups experienced a rise in TTW 17 days post-banding, as compared to the corresponding 
sham- and baseline values (Figure 19).  Largest increases were, however, noted in the RVbasis, 
with a relative TTW increase of ~60% as compared to the corresponding baseline value 
(PA17d 6.8 vs. CtrBL 4.2±0.2), and a ~70% increase as compared to the corresponding sham 
(PA17d 6.8 vs. Sham17d 4.0) (Figure 19).  Septumapex represented the second highest increase in 
TTW after 17 days of PA-banding, with a TTW increase of ~30-50% as compared to the 
corresponding baseline- and sham value (PA17d 5.6 vs. CtrBL 4.3±0.2 and Sham17d 3.7) (Figure 
19). 
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Figure 19.  The spatial distribution of the total tissue water (TTW) in the heart.  No statistical 
differences were seen within the acute protocols (30-/60 minutes of PA-banding) in the PA-banded 
groups as compared to the respective sham- and baseline values.  However, a general decreasing 
trend in the TTW was seen in the left ventricle (LV), only showing statistical difference in the 
sham values of the LVmid after 60 minutes of PA-banding and the LVapex after 30- and 60 minutes 
of PA-banding, as compared to the corresponding baseline values.  Most pronounced increases in 
TTW were seen in the preliminary data 17 days post-PA-banding, with the largest increases in the 
RV basis.  Symbols with error bars represent group means ± SEM.  #p<0.05 vs. initial pressure 
measured pre-PA-banding (0’).  n=6 animals at all measured time points in the acute experimental 
groups, whereas chronic experimental groups were represented by: Sham24h (n=3); Sham17d (n=1); 
PA24h (n=2); PA17d (n=1).  ‘, minutes; h, hours; d, days. 
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3.4.1 Oedema Formation within the Different Ventricles of the Heart 
During the process of determining the temporal development of myocardial oedema, the 
possible spatial distribution (described in section 3.4) of the total tissue water (TTW) of the 
heart myocardium was additionally explored from another perspective.  Basis, mid- and apical 
sections from the right- and left ventricles and the septum, were summed to represent the 
respective ventricular TTW within the different experiments (Figure 20).  By presenting the 
data in this way, i.e. by summing the three gradient sections (basis, mid and apex) to give 
right ventricle (RV), septum or left ventricle (LV), the general picture of the TTW-trends 
between the heart ventricles were easier to interpret.  A baseline control group (i.e. the 
component concentration level before introducing animals to experimental conditions) was 
additionally included in the protocols to represent the basal level of the TTW. 
 
Figure 20.  Illustration of the sectioning of the heart as used in the 
analysis of myocardial oedema.  Heart was divided into right ventricle 
(RV), left ventricle (LV) and septum (S). 
 
The LV pulmonary artery (PA) banded groups of the acute protocols (30-/60 minutes of PA-
banding) experienced decreases in TTW after 30- and 60 minutes of banding, as compared to 
the respective baseline value (PA30min 4.2±0.1 and PA60min 4.1±0.1 vs. CtrBL 4.6±0.1, P<0.05) 
(Figure 21).  No differences were, however, seen in the RV or septum TTW of the PA-banded 
experimental groups, as compared to the corresponding shams or baseline values. 
Focusing on the chronic phase (24 hours/17days of PA-banding), representing, however, only 
preliminary data, TTW did not seem to have changed after 24 hours, but after 17 days, the 
TTW was markedly increased in the PA-banded groups as compared to the corresponding 
baseline values (Figure 21).  Largest TTW increases were seen in the PA-banded RV, with a 
relative increase of ~40% as compared to the baseline- and sham value (PA17d 5.9±0.5 vs. 
CtrBL 4.2±0.1 and Sham17d 4.1±0.0), followed by a LV increase with a relative change of ~20-
40% (PA17d 5.6±0.1 vs. CtrBL 4.6±0.1 and Sham17d 3.9±0.1) (Figure 21).  Although data from 
17 days of chronic protocols were represented by only one animal, figure and statistics were 
based on the number of samples in each group, hence, giving SEM values for these 
experiments. 
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Figure 21.  Total tissue water (TTW) of the right- and left ventricles and the septum.  Left 
ventricular (LV) TTW was significantly decreased in the pulmonary artery (PA) banded groups 
30- and 60 minutes post-banding.  Moreover, a marked, but a non-statistically provable (due to the 
same origin of the test samples) increase were seen in the PA-banded groups 17 days post-banding 
as compared to the corresponding shams and baseline values.  Symbols with error bars represent 
the summed test sample means ± SEM.  Hence, the one animal representing the 17 day 
experimental groups are presented with SEM values.  #p<0.05 vs. baseline value (0’).  n=18 test 
samples (6 animals) at all measured time points of the acute experimental groups, whereas chronic 
experimental groups were represented by; Sham24h (n=9; 3 animals), Sham17d (n=3; 1 animal), 
PA24h (n=6; 1 animal), PA17d (n=3; 1 animal).  ‘, minutes; h, hours; d, days. 
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3.4.2 Oedema Formation within the Heart 
An additional view of the oedema formation in the heart was obtained by exploring it as a 
whole, i.e. all test samples within the same experiment were summed to represent the TTW of 
the whole heart, thus yielding nine test samples from one animal.  A baseline control group 
(i.e. the component concentration level before introducing animals to experimental 
conditions) was included in the protocols to represent the basal level of the total tissue water 
(TTW). 
No differences in TTW were seen in the acute protocol (30-/60 minutes of PA-banding) 
(Figure 22).  Preliminary data from the chronic protocol (24 hours/17 days of PA-banding) 
demonstrated a marked TTW increase in the experimental pulmonary artery (PA)banded 
group after 17 days of banding (with the 17 days time point representing nine test samples 
from one animal, hence presented with a SEM value), showing a relative increase of ~25% as 
compared to the baseline value (PA17d 5.6±0.2 vs. CtrBL 4.4±0.1) and ~40% as compared to 
the corresponding sham (PA17d 5.6±0.2 vs. Sham17d 4.0±0.0) (Figure 22). 
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Figure 22.  Total tissue water (TTW) of the whole heart.  No differences in TTW were seen 
until 17 days post pulmonary artery (PA) banding, however, represented only by preliminary data.  
Symbols with error bars represent the added test sample means ± SEM.  Hence, the one animal 
representing the 17 day experimental groups are presented with SEM values.  n=54 samples test (6 
animals) at all measured time points of the acute experimental groups, whereas chronic 
experimental groups were represented by; Sham24h (n=27; 3 animals), Sham17d (n=9; 1 animal), 
PA24h (n=18; 2 animals), PA17d (n=9; 1 animal).  ‘, minutes; h, hours; d, days. 
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3.5 Total Collagen Content in the Heart 
Davis et al. (13) has previously demonstrated that myocardial oedema preceded an increased 
collagen deposition, i.e. fibrosis, and suggested that the oedema played a central role, 
triggering collagen synthesis and deposition.  Along with the investigation of the temporal 
development of myocardial oedema, subsequent to banding the pulmonary artery (PA) in the 
in vivo rat model, total collagen content was examined to determine the temporal development 
of fibrosis formation.  Due to the limited amount of time available for this Master’s thesis, 
only right ventricular (RV) apical areas were examined.  Furthermore, due to a large number 
of samples, collagen analysis was separated into two series.  Experimental results were 
thereby based on two different sets of standard curves (Appendix A).  The first series of 
samples were, however, not completely hydrolyzed due to insufficient dilution.  Thus, these 
samples might have contained increased amounts of sodium chloride, depressing chromogen 
formation; resulting in falsely lowered hydroxyproline concentrations and subsequent 
collagen contents.  Baseline controls (i.e. the component concentration level before 
introducing animals to experimental conditions) were included to represent the basal level of 
the total collagen content. 
No significant changes in collagen content were detected in the acute PA-banded 
experimental groups as compared to the baseline value (Figure 23).  However, a statistical 
increase was seen after 60 minutes of banding in the sham group as compared to the 
corresponding PA-banded group (Sham60min 3.2±0.7mg/g dry weight (DW) vs. PA60min 
5.0±0.1mg/g DW, p<0.05).  Moreover, although not statistically proven due to only one 
animal representing the experimental group, ~140% increase in collagen content was seen 
after 17 days of banding in the PA-banded experimental group as compared to the control 
baseline value (CtrBL 3.5±0.9mg/g DW vs. PA17d 8.4mg/g DW), in addition to ~40% increase 
as compared to the corresponding sham value (Sham17d 5.9mg/g DW vs. PA17d 8.4mg/g DW) 
(Figure 23). 
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Figure 23.  Total collagen content of the right ventricular (RV) apex.  No significance was 
seen in the pulmonary artery (PA) banded groups as compared to the baseline value throughout 
acute experimental protocols (30-/60 minutes of PA-banding).  However, a difference was 
detected in the sham group 60 minutes post-PA-banding.  Preliminary data from the chronic 
protocols showed a visual increase in the PA-banded group as compared to the corresponding 
sham and baseline value.  *p<0.05 vs. corresponding sham group.  n=6 animals in all measured 
time points except for the experimental groups; Sham24h (n=3), Sham17d (n=1), PA24h (n=2), PA17d 
(n=1). ‘, minutes; h, hours; d, days. 
 
3.6 Skeletal muscle and Lung Controls 
Control samples from skeletal muscle and lungs were included to determine if an eventual 
increase in total tissue water (TTW) or collagen content was specific to the myocardium, or if 
the oedema/fibrosis formation was generalized- and/or additionally located to the lungs.  
Skeletal muscle analysis showed no statistical variation in TTW or collagen content in the 
PA-banded groups as compared to the corresponding sham groups or baseline values.   
Lung TTW revealed a statistical increase after 60 minutes of banding in both the PA-banded- 
and the sham group as compared to the baseline value (PA60min 5.7±0.3 and Sham60min 4.9±0.2 
vs. CtrBL 4.4±0.1, p<0.05) (Figure 24).  Moreover, the PA-banded group was significantly 
increased as compared to the sham group 60 minutes post-PA banding (Sham60min 4.9±0.2 vs. 
PA60min 5.7±0.3, p<0.05) (Figure 24).  However, the TTW increase seen 60 minutes post-
banding did not continue into the chronic protocols (24 hours/17 days of PA-banding) (Figure 
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24).  The subsequent analysis of total collagen content in the lungs revealed no differences 
between the experimental groups. 
 
n=6 n=6 n=6
n(Sham)=9
n(PA)=6
Time
0' 30' 60' 24h 17d
TT
W
 (A
U
)
4
5
5
6
6
Sham
PA-banded
#
*
#
n(Sham)=3
n(PA)=2n=6 n=6 n=6 n=1
 
Figure 24. Total tissue water (TTW) of the lung.  A general increase in TTW was seen in the 
lungs during the acute procedures (30-/60 minutes of PA-banding), represented by a statistical 
increase after 60 minutes of banding in both the PA-banded- and sham group as compared to the 
baseline value.  Moreover, the PA-banded group was significantly increased as compared to the 
sham group 60 minutes post-PA banding.  However, the TTW increase seen 60 minutes post-
banding did not pursue into the chronic protocols (24 hours/17 days of PA-banding).  Symbols 
with error bars represent group means ± SEM.  *p<0.05 vs. corresponding sham group; #p<0.05 
vs. initial pressure measured pre-PA-banding (0’).  n=6 animals at all measured time points in the 
acute experimental groups, whereas chronic experimental groups were represented by: Sham24h 
(n=3); Sham17d (n=1); PA24h (n=2); PA17d (n=1).  ‘, minutes; h, hours; d, days. 
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3.7 General Body- and Tissue Weights 
No statistical difference in body weights were seen between the various experimental groups, 
representing average rat weights prior to surgical procedures of 287±6g for acute- and 
349±11g for chronic experimental groups, respectively.  Rats undergoing 24 hour chronic 
procedures had generally lost ~5g of body weight at time of re-opening as compared to before 
surgical procedures, whereas rats undergoing 17 days of chronic procedures had similarly 
gained ~5g of body weight. 
No variation in heart weights were seen between the experimental groups, except for the one 
animal undergoing 17 days of PA-banding that showed a weights increase of ~80% as 
compared to the corresponding sham and baseline heart weights (PA17d 2.26g vs. Sham17d 
1.28g and CtrBL 1.24±0.07g). 
No variation was detected in lung- or skeletal muscle weights as PA-banded groups were 
compared to the corresponding sham groups and baseline value.   
  
  
4 Discussion 
The scope of this Master’s thesis was threefold.  Firstly, in the process of establishing an in 
vivo rat model of pulmonary artery (PA) banding, i.e. by reducing the diameter of the PA, the 
right ventricular developed pressure (RVDP) was expected to increase, subsequently giving 
rise to myocardial oedema and increased collagen deposition.  Changes in heart function 
variables, such as RVDP, right ventricular (RV) contractility and rate of relaxation (dP/dt), in 
addition to heart rate (HR), verified the experimental model.  Secondly, the goal was to 
investigate the temporal development of oedema formation and subsequent changes in 
collagen content.  Thus, an acute protocol (30-/60 minutes of PA-banding) and a chronic 
protocol (24 hours/17 days of PA-banding) were studied to reveal the time points at which 
changes took place.  Thirdly, in addition to exploring the temporal development of 
myocardial oedema and collagen changes, the potential spatial distributional development 
within the myocardial interstitium was investigated. 
Within the time limit available for this Master’s thesis, the acute part and immediate post-
banding period obtained most of the attention.  Nevertheless, the acute experiments 
demonstrated satisfactory cardiac function.  Furthermore, the long term surviving animals 
demonstrated that this level of banding seemed appropriate for long term experiments. 
 
4.1 Central Findings 
4.1.1 Verification of the Pulmonary Artery Banded in vivo Model 
Pulmonary artery (PA) banding induces myocardial oedema not only in the right ventricle 
(RV) where the pressure is increased, but also in the left ventricle (LV), since thebesian veins 
and sinus venosus together drain the RV and the LV.  As LV venous drainage enters the right 
atrium through the coronary sinus, a RV pressure increase leads to a subsequent coronary 
sinus pressure elevation, thus increasing LV microvascular exchange vessel pressure and 
trans-microvascular fluid flux, leading to a left sided oedema.  Moreover, as cardiac lymph 
drains into the central venous system, the pressure elevations leads to a decreased rate of 
removal of oedema fluid from the LV, further accumulating interstitial water.  Since only the 
50 
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RV experiences pressure overload and a subsequent hypertrophic myocardium, the effects of 
the LV oedema formation can be studied without interferences from manipulation of the LV 
itself. 
We demonstrated a marked experimental response when permanently reducing the diameter 
of the PA by banding, in which continuous RVDP elevations of ~50-100% were reported.  
The permanent reduction of the PA-diameter resulted in a continuous RVDP elevation of ~50-
100% in the PA-banded rats throughout the experimental protocols.  This relative increase in 
RV pressure is consistent with other studies, Davis et al. reporting a relative increase of 46-
144% in RVDP when constricting the PA to the same diameter (against a 16G luer stub 
adapter) in a similar rat model, and further, ~100% increase in canine models of PA-banding 
(6, 13).   
When increasing the RVDP by PA-banding, we postulated that an immediate compensation 
would take place, lasting as long as the heart would be able to overcome the increased 
pressure.  We expected to see a steady increase in the heart rate (HR) paralleled with a 
decrease in the contractility performance and rate of relaxation (dP/dt) as the myocardial 
oedema would progress.  The background for this was that, since oedema is associated with 
increased chamber stiffness, the quality of each contraction and subsequent relaxation (dP/dt) 
would deteriorate, resulting in a larger compensation through a increased HR.  A study 
performed in dogs by Laine (35), analyzing the contractility in the LV after occluding the 
coronary sinus pressure, supported the hypothesis of a decreased dP/dt as oedema progressed.  
Their experimental records showed an immediate increase in dP/dt maximum, lasting only 
shortly though, before a steady decrease was seen as oedema evolved.  Although our study 
measured dP/dt in the RV, similar results as Laine (35) were expected.  From the time of PA-
banding and onwards, we experienced significantly improved contractility performances with 
subsequent relaxation, while HR remained unchanged in the larger part of the experimental 
procedures.  Urashima et al.(54) support this finding, reporting an immediate dP/dt increase 
post-banding in a murine model of PA-banding.  Within the time frame available for this 
Master’s thesis, especially chronic protocols were represented with a limited amount of 
experimental data.  With only one PA-banded rat surviving 17 days of PA-banding, only 
preliminary conclusions of the results should be made.  Nevertheless, the preliminary data still 
showed an improved dP/dt, indicating that the heart was still trying to compensate for the 
increases in RV pressure through an increased contraction, followed by better relaxation. 
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4.1.2 Temporal Development of Myocardial Oedema and Fibrosis 
By determining the temporal development of myocardial oedema and subsequent fibrosis 
formation in an established pulmonary artery (PA) banded model, this model could be used in 
the specific process of revealing an effective treatment method for oedema- and fibrosis 
associated diseases.  Furthermore, verifying the exact timeframe for oedema- and fibrosis 
development could reveal the optimal time point for administration of prophylactic 
interventional treatments.  Nedrebø et al. (55) has previously shown insulin to prevent a 
lowering of the interstitial fluid pressure (Pi) during inflammation in the rat skin, attenuating 
oedema formation after an intravenous treatment of pro-inflammatory cytokines 
(lipopolysaccharide (LPS), tumor necrosis factor-α (TNF-α) and interleukin-1β) that are 
known to be produced by many cells during acute and chronic inflammation.  The potential 
anti-inflammatory and anti-oedematous effects of insulin should thus, also be investigated in 
the heart (section 4.3). 
Our results were based on both acute- and chronic protocols, with rats undergoing 30-/60 
minutes and 24 hours/17 days of PA-banding, respectively.  Data were explored in three 
different ways to view the results from different spatial aspects.  By doing so, both overall- 
and more specific regional changes were easier to detect.  Nevertheless, the analyses revealed 
similar overall temporal trends.  Total tissue water (TTW) did not significantly increase 
within the first hour after PA-banding, indicating that oedema is not developing within this 
timeframe.  These results also indicate that the Starling forces are still kept within steady state 
and that the three consecutive lines of defence described by Aukland (28), i.e. the local factors 
regulating the interstitial fluid volume, are still compensating for the increased RV pressure.  
Due to a limited number of animals in the chronic experimental protocols, results should be 
considered as preliminary indications.  The preliminary results from chronic protocols showed 
the expected trend of oedema formation in the PA-banded groups after 17 days of 
experimental banding.  However, after 24 hours of banding, we experienced opposite trends, 
with TTW elevations in the sham higher than the PA-banded experimental group.  The 
mechanism behind this occurrence is unknown, and may be incidental and possibly altered 
when increasing the number of animals in the experimental groups.   
Myocardial oedema was expected to have developed within 24 hours, as previously shown by 
others, e.g. Davis et al. (13) who demonstrated a marked increase in TTW after 24 hours of 
PA-banding, utilizing the same experimental rat model as us, i.e. the study was performed in 
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male rats within a similar weights range, in addition to reducing the diameter of the PA 
similarly to yield a PA-thickness of 1.52 mm (by tightening the PA against a 16G luer stub 
adapter).  Additionally, their permanent reduction in PA-diameter resulted in an RVDP 
elevation of 46-144% (13), similarly to us, reporting continuous RVDP elevations of ~50- 
100% post-PA-banding.  The only difference regarding RV pressures were the initial starting 
points, with Davis et al. (13) reporting pressure-means of 9-13mmHg as compared to our 23-
24±1mmHg.  If the ~10mmHg pressure difference is due to the measuring technique or 
equipment may only be speculative.  As will be mentioned in section 4.2.3, we examined 
different cannula-sizes to find the smallest one providing us with least chance of bleeding and 
damage to the rat myocardium, but yet steady signals, and found this to be the 25G cannula.  
Testing the smaller 27G needle as used by Davis and co-workers, it did not provide us with 
any reliable pressure signal.  Nevertheless, as long as the relative pressure increases were 
withheld, the initial starting pressure would be expected to have minor consequences on the 
results.  The eventual discussion may, however, be focused towards methodological aspects of 
the weighing and drying of the sample tissues.  Davis et al. (13) dried the tissue until constant 
weight, in comparison to freeze drying the samples overnight as done in our study.  As will be 
described (section 4.2.4), possible variations within the two methodological methods should 
be investigated.  It is also important to note that the differences in TTW are rather small and 
may easily be overlooked without careful quantification.  Optimizing quantification- and 
analysis techniques would be particularly important in the search for the temporal progression 
of TTW from normal limits to oedema.   
Myocardial interstitial fibrosis is a common manifestation in response to the presence of 
myocardial oedema, and is known to compromise cardiac function (7, 13, 43, 56).  Thus, as 
no myocardial oedema seemed to be developed within the first hour of PA-banding, neither 
collagen content was expected to be raised.  Results from the collagen analysis of the RV 
apex were consistent with these expectations.  Davis et al. (13) reported elevated TTW and 
oedema formation after 24 hours of PA-banding, preceded by an increased collagen synthesis 
after 7 days.  As the collagen content was not increased after 3 days, i.e. the first measured 
time point after 24 hours, but after 7 days of PA-banding, this demonstrated that the increased 
collagen synthesis took place between 3-7 days post-PA-banding (13).  As our preliminary 
data indicated that an oedema was present 17 days post-PA-banding, total collagen content 
might also be expected to be increased by this time.  Subsequent collagen analysis of the RV 
apex revealed that collagen content seemed to be increased.  The level of total collagen 
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content was, however, in general about 10-fold lower than that of other reported levels of total 
collagen content in the myocardium (7, 13).  Davis et al. (13) reported RV baseline values of 
27±0.46mg collagen/g dry weight (DW) as compared to our level of 3.5±0.89mg collagen/g 
DW in the RV apex.  This difference may well be related to the insufficient dilution during 
the first analytic series.  Even when dilution was correctly performed, the present values were 
well below those of Davis et al. (13).  Hence, it will require follow-up studies to clarify this 
discrepancy.  Nevertheless, Davis and co-workers reported a 3.7-fold increase in total 
collagen content 28 days after PA-banding, which correlated well with the 2.4-fold increase 
that we demonstrated in our study (13).   
 
4.1.3 Spatial Development of Myocardial Oedema and Fibrosis 
Acute experimental protocols (30-/60 minutes of PA-banding) demonstrated that myocardial 
oedema was not developed within the first hour of PA-banding in our in vivo rat model.  
Preliminary results from chronic protocols (24 hours/17 days of PA-banding) indicated, 
however, presence of oedema 17 days post-PA-banding, although based on only one 
experiment, with large increases in the total tissue water (TTW) located to all the investigated 
tissue regions.  However, the largest relative TTW increase was seen in the right ventricle 
(RV), and within the RV, the basis sectioned TTW was elevated the most.  Further 
investigations of the time points around the developing phase of myocardial oedema would be 
essential in the process of revealing exact spatial distributions of the TTW in oedema 
situations, in which the individual TTW increases and progressions to give oedema would be 
easier to reveal.  Water content in the different regions of the oedematous heart myocardium 
has previously been elucidated in the domestic swine by Jia et al. (57), provoking oedema by 
hemodilution.  Gradient TTW differences were demonstrated within the ventricles and 
septum, with the largest amounts reported in the RV free wall, followed by septum and the 
left ventricle (LV) (57).  It was suggested that the mechanism behind the findings of higher 
TTW indexes in the RV and septum could be related to their lower myocardial tissue 
pressures, diminished vascularity, and lower blood flow as compared to the LV (57).  One 
could also speculate if the RV becomes oedematous because of the thin-walled structure, that 
the strong mechanical activity of the LV enhances lymph flow, thus reducing the oedema 
development.  Our preliminary finding of the largest amount of TTW in the RV is, thus, so far 
working in concordance with literature (57).  Inter-ventricular TTW differences have also 
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been observed by others (9, 13).  Pratt et al. (9) observed in a canine model of coronary sinus 
hypertension that the RV and LV TTW was increased, whereas the septum TTW remained 
unchanged.  Moreover, Davis et al. (13), investigating only the right- and left ventricular 
TTW in a PA-banded rat model, noted increases in both ventricles, however, with a larger 
TTW increase in the RV than the LV.  Jia and co-workers elucidated additionally to the 
gradient differences within the heart ventricles and the septum, also internal TTW differences 
within the LV free wall (57).  TTW seemed to accumulate to a higher extent in the apical 
areas of the LV, followed by mid sections and the basis (57).   
As the collagen content was only analyzed within the right ventricular apex, no spatial 
distributional findings and subsequent interpretations was possible.  However, as myocardial 
interstitial fibrosis supposedly is a manifestation in response to the presence of myocardial 
oedema, fibrosis would be assumed to be related to the amount and regional locations of the 
oedema. 
 
4.2 Methodological Aspects 
4.2.1 Animals 
Experimental procedures were performed on male Wistar rats.  Rats are among the most 
commonly used animals in experimental work, as they are easily bred and handled; in 
addition that housing can be limited to a relatively confined area.  This is not only important 
for practical reasons, but also economical.  Subsequently, the anatomy, physiology, genetics 
and behaviour is well elucidated, giving results that, if interpreted with consideration, to some 
extent can be extrapolated to humans. 
Optimizing handling- and surgical technique were main focuses during preparations in order 
to minimize stress in animals throughout the experimental procedures.  This was due to the 
fact that stress is highly associated with increased physiological and biochemical results 
variability. 
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4.2.2 Anaesthesia 
Animals were subjected to the following anaesthetic regime to provide minimum stress and 
pain throughout the experimental procedures: 
1. Pre-anaesthetic care: Hypnorm (Fentanyl citrate and Fluanisone) or Mebumal 
(pentobarbital) 
2. Peri-anaesthetic care: PropoVet (propofol) 
3. Post-anaesthetic care: EMLA cream (lidocain and prilocain) and Temgesic 
Animals were treated with pre-anaesthetic care in order to provide a stress-free induction 
phase for the animals during the intravenous (i.v.) cannulation of the tail vein.  Brammer et al. 
(50) previously described Hypnorm to produce heavy sedation, in addition to work well in 
combination with propofol.  With this in mind, Hypnorm was chosen as pre-medication.  We 
experienced an unfortunate and sudden delivery stop from the manufacturer in the middle of 
surgical experiments, so that Hypnorm was temporarily unavailable.  Hypnorm was 
consequently substituted with Mebumal, a commonly used anaesthetic in circulatory research, 
having few circulatory side effects.  Being a barbiturate and not an analgesic, we experienced 
calm animals prior to the i.v. cannulation, but a slightly larger reaction response during 
insertion of the cannula.  However, animals seemed to respond quickly to the subsequent i.v. 
bolus injection of PropoVet, resulting in deep anaesthesia.  Furthermore, by changing the pre-
anaesthetic regime from Hypnorm to Mebumal, hemodynamic parameters did not seem 
change, thus indicating no effects between the two. 
Brammer and colleagues has previously shown in a study comparing various injectable 
anaesthetic agents and combinations, that propofol, with Hypnorm pre-medication provided 
stress-free induction, easily controlled anaesthesia, good analgesia and muscle relaxant for 
surgery, up to 3 hours duration (50).  Moreover, stable and normal heart rates (HR), blood 
pressures and respiration rates were reported (50).  By obeying the recommendations of 
keeping a continuous infusion of 4-6mL/kg/h propofol to maintain deep anaesthesia 
subsequent to pre-medication and a propofol bolus dose, we experienced deeply anesthetized 
rats (50).  However, cardio-depression and death were frequently experienced, particularly in 
many of our acute procedures as these surgical protocols lasted longer than the chronic 
procedures.  By reducing the PropoVet dosage to a minimum, nevertheless, still providing 
adequate- and deeply anaesthetized rats, cardio-depression was no longer experienced, which 
indicates a possible concentration dependency of propofol.  Indeed, this has previously been 
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suggested, e.g. Hamilton et al. showed in their study that propofol produced a concentration-
dependant reduction in evoked contraction at concentrations greater than 5µM, with 
maximum effect observed at >100µM (58).  Various mechanisms for this propofol-induced 
inotropy have been suggested, e.g. (1) K+ channel mediation, when studied in atrial muscle 
(59) and (2) Ca2+ uptake capacity impairment of the sarcoplasmatic reticulum in 
cardiomyocytes (60).  However, a study performed by Riou and co-workers (61) in vitro to 
avoid impact from changes in preload, systemic resistance, baroreflex activity, and central 
nervous system activity, showed only moderate changes on the intrinsic myocardial 
contractility, suggesting that cardiovascular depression seen with propofol in vivo was not 
related to an intrinsic myocardial depression.  Whether propofol contributes to a direct 
negative inotropic effect is obviously controversial, even though most authors agree that it 
induces cardiovascular depression.  However, propofol should not only be associated with 
adverse effects, in which one great advantage was the rapid recovery time after disconnecting 
anaesthesia after the surgical procedure in the chronic protocols.  An additional advantage of 
regaining consciousness quickly after surgery, was the opposed risk of serious hypothermia in 
the animals.  Anaesthesia and surgery commonly cause hypothermia, resulting from a 
combination of a cool (colder than body temperature, 37°C) operating room and an 
anaesthetic-induced impairment of the thermoregulatory control (62).  Hypothermic animals 
will have a decreased metabolism and circulation, which, in addition to influencing the 
experimental results, will prolong recovery time after surgery.  To avoid heat loss and 
hypothermia, the anesthetized animals were placed onto a temperature controlled operation 
tablet.  Regular control of both rectal and thorax (under surgery) temperatures assured optimal 
temperature conditions for the animals during surgery and post-surgically, until normal 
thermoregulatory mechanisms were recovered. 
 
  
DISCUSSION 
58 
 
4.2.3 Surgical Procedure – Considering Possible Sources of Errors  
The heart and pulmonary artery (PA) was accessed via median sternotomy, a normal, but 
extensive procedure in cardiothoracic surgery.  The pericardium is a thin, fibrous, bag-like 
structure within which the heart lays, only separated by a small amount of lubricating fluid to 
allow smooth movement of the heart during contraction and relaxation, without disturbances 
of the surrounding lungs.  To reach the PA, the pericardium was opened.  Leaving the 
pericardium open after cardiothoracic surgery is a routine practise in man, hence, being one 
reason for doing so also when closing the animals after surgery in the chronic protocols.  In 
addition, being a thin and delicate membrane, the rat pericardium would be difficult to close.  
Moreover, hemodynamic performance is said to be generally better when the pericardium is 
left open, in addition to reducing the risk of cardiac tamponade (63). 
The PA-banded procedure was performed by dissecting the PA from the surrounding tissue, 
mainly aorta, followed by passing and tightening a silk suture around to elevate the 
ventricular pressure.  Cardiac function and fluid balance may not, however, only have been 
influenced by the PA-constriction itself, but also by the extensive surgical intervention and 
the short occlusion during PA-banding, when tightening the suture against the luer stub 
adapter.  However, by including sham controls that are regarded as placebo controls in 
experimental procedures, and the most rigorous comparator by which to assess the efficacy of 
an intervention, this possible source of interference was considered.  
 
Right ventricular developed pressure (RVDP) was measured in order to verify changes in the 
PA-pressure pre- and post-PA-banding.  As a PA-catheter is difficult to place in rats, RVDP 
was measured by placing a 25G i.v. cannula directly into the lumen of the right ventricle 
(RV).  This is an invasive procedure that possibly could interfere with hemodynamics and 
cardiac physiology, in which the cannula perforated the RV myocardial tissue later sampled 
for oedema- and fibrotic analyses.  Optimally, to reduce the impacts on the experimental 
results from these measurements, pressure and HR signals from various sized cannulas and 
syringes were tested in advance, in order to find the smallest functional cannula giving least 
perforation through the RV.  The 25G cannula was the smallest one giving satisfying and 
steady signals, thus used in the experiments.  As previously stated, sham controls were 
important in the process of revealing these possible additional interferences.  The i.v. cannula 
was attached to a fluid-filled catheter, further connected to PowerLab for hemodynamic 
pressure- and heart rate (HR) measurements.  Hence, PowerLab measures the transferred 
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pressure- and rate of the fluid filled in the catheter and not directly on the actual blood.  Air 
trapped in the system was avoided and always checked prior to measurements, as pressure 
transferred via intermediate air bubbles consequently would result in a dampening of the 
signal.  The PowerLab was calibrated prior to every experiment to assure optimal 
measurements, since systemic drifting could be expected from time to time. 
Adult rats have a blood volume of approximately 70mL/kg, giving a total of 14mL of blood in 
a 200g weighed rat (52).  10% of this volume may be withdrawn at once without particular 
side effects, whereas a larger removal (>20-25%) will produce signs of hypovolemia, in 
addition to being a supplemental source of variable and inconsistent experimental results (52).  
To keep track of blood status, haemoglobin and hematocrit-levels were regularly monitored 
when blood was sampled.  Blood samples were also taken to monitor blood gases and glucose 
levels.  Samples were drawn from the RV, containing venous and oxygen-poor blood.  Blood 
gases are, however, optimally sampled arterially for lung status, but in our case, to obtain an 
approximate status of the artificial ventilation, venous blood was regarded as sufficient.  
Glucose analysis was included to monitor the glycemic status, i.e. to assure that none of the 
rats were hypo- or hyperglycaemic.  After sampling, and also throughout the surgical 
protocol, blood volume was replenished by regularly infusing saline, in order to prevent 
hypovolemia in the animals.  Excessive hypovolemia may occur post-operatively, in which 
animals may not drink within the first 12-24 hours (52).  Thus, animals undergoing chronic 
procedures were administrated three times a day with ~3mL of saline infusion s.c. during 
recovery the first two days post surgery, due to the approximate requirements of 40-
80mL/kg/24 hours for most animals (52).  
 
4.2.4 Myocardial Oedema – Method Evaluation 
Determination of total tissue water (TTW) and oedema formation was performed by freeze-
drying the samples (section 2.5).  Another, and perhaps more commonly used and well 
established method in research is the drying chamber, drying tissue in a temperature of ~50°C 
until constant weight.  The offset for not utilizing this method was the limited possibilities for 
using the tissue subsequently.  In which overnight freeze-drying not only is time-saving, but 
also tissue-preserving, it could have been interesting to investigate possible results-differences 
between the two methods. 
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4.2.5 Collagen Content – Hydroxyproline Analysis 
Total collagen content was analyzed according to the method described by Woessner (53), 
based on a hydroxyproline colorimetric assay.  Hydroxyproline is widely used as a co-
determining indicator of collagen content.  This analytical assay is manual and stepwise, 
additionally to being highly depending on precision and accuracy regarding volumes, reaction 
times- and temperatures, and is thus, associated with several pitfalls.  The method is generally 
well established in our lab, so that volumes, concentrations and temperatures were already 
optimized.  However, neither heart nor lung samples had previously been analyzed before in 
our group.  The hydroxyproline assay as described by Woessner (53), included two different 
protocols depending on the amount of hydroxyproline expected to be found in the respective 
tissue (Method I: for samples containing >2% hydroxyproline; Method II: for samples 
containing <2% hydroxyproline).  Based on hydroxyproline content normally found within 
the myocardium and lungs, method I was used.  However, as heart and lungs were analyzed 
for the first time in our laboratory, and as for other tissue, the protocol should have been 
optimized for these tissues.  Further follow-up and fine tuning in our laboratory will be 
required before this is a routine analysis for collagen in heart and lungs.  
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4.3 Future Perspectives 
The present study opens for many further studies. First of all, the number of animals in the 
chronic experimental groups needs to be increased in order to conclude on the oedemic- and 
fibrotic responses in the in vivo experimental model of pulmonary artery (PA) banding.  It 
would also be necessary to conduct more experiments, investigating the process of the 
temporal and potential spatial distribution of myocardial oedema and fibrosis development.  
Expanding acute protocols to 3- and 6 hours would be essential in the further process of 
investigation, because increased TTW, i.e. myocardial oedema, has previously been 
demonstrated after 3 hours of coronary sinus pressure elevations in a canine model (7), 
indicating that this also could be the case for rats.  Even though we did not even demonstrate 
oedema formation after 24 hours of PA-banding, increasing the number of animals in the 
experimental group could yield other findings.  Moreover, expanding chronic protocols to 
include also 5-, 7- and 12 days of PA-banding would be essential in the process of 
determining the temporal and potential spatial distribution of a collagen content increase and 
fibrosis formation. 
Further, gene-regulations and histology markers should be included in future studies, as well 
as determination of the ability of matrix metalloproteinases (MMPs) breaking down collagen, 
as a process of investigating the oedema development and subsequent collagen deposition.  
Computerized morphometry on Sirius-red stained tissue sections, in addition to investigating 
other markers of fibrosis, e.g. by Western blotting, confocal and fluorescent microscopy, or 
electron microscopy (EM) should be included. 
Temporal development of both myocardial oedema and fibrosis would be important to 
elucidate in an established PA-banded experimental model, also with a clinical application in 
mind.  Insulin therapy has previously been shown by Nedrebø et al. (55) to prevent a lowering 
of the interstitial pressure (Pi) during inflammation in the rat skin, attenuating oedema 
formation.  The potential anti-inflammatory and anti-oedematous effects of insulin should, 
thus, also be investigated in the heart.  Hence, in order to find the most effective time for 
therapeutic treatment, in addition to answering how optimal administration should be carried 
out, the temporal time for oedema- and fibrosis formation should be investigated.   
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Appendix A 
Determination of Hydroxyproline 
The starting material for this analysis is freeze dried samples. 
1. Hydrolysis 
a. Fat free freeze dried samples are finely chopped on a small, smooth paper piece using 
a scalpel (alternatively use a homogenisator).  The chopped samples are weighed (set 
to “home” and registered with 5 decimals).   
b. Transfer to a 4mL glass tube with a tight screw top and add: 
i. 0.5mL dH2O 
ii. 0.5mL 12N (37%) HCl 
Mix i. and ii. before adding to sample glass tube 
c. Put the samples in a heating chamber keeping 120°C overnight (~16 hours) 
d. Let samples cool down to reach room temperature and dilute with 3mL dH2O, giving a 
total volume of 4mL. 
e. Samples are further diluted: 
i. µL suspension: (225/Xmg sample/4mL))×5 
ii. µL dH2O: to a total of 4500µL 
Use 7mL tubes with blue screw top.    
Tissue concentration now is 0.25µg/ µL or 125µg dry tissue in 500µL suspension. 
2. Reagents 
a. Citric acid buffer:  
50g Citric acid monohydrate (ܥ଺ܪ଼ܱ଻  ൈ ܪଶܱ, ܯ௪ ൌ 210.14 ) 
12mL Acetic acid (ܥܪଷܥܱܱܪ, ܯ௪ ൌ 60.05) 
120g Na-acetate trihydrate (ܥܪଷܥܱܱܰܽ  ൈ 3 ܪଶܱ) or 72.37g Na-acetate 
without H2O (ܯ௪ = 82.03) 
34g Na-hydroxide (ܰܣܱܪ, ܯ௪ ൌ 40) 
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Dissolve in dH2O (Note: Hot.  May alternatively be cooled on ice) and adjust 
(with dH2O) to a total of 1 litre and pH to 6.0 (adjust with 1M or 5M NaOH or 
HCl). 
Store at 4°C. 
  
b. 3.15M Perchloric acid: 
27mL 11.65M (70%) or 34.2mL 9.2M (60%) Perchloric acid (ܪܥ݈ ସܱ,  ܯ௪ ൌ
100.47) is solved with dH2O to a total volume of 100mL. 
 
c. 0.05M Chloramine T: 
1.41g Chloramine T ሺܥ଻ܪ଻ܥ݈ܱܰܰܽଶܵ  ൈ 3ܪଶܱ, ܯ௪ ൌ 281.61ሻ (note: 
Chloramine T powder must be white) 
20mL dH2O 
30mL Ethylene glycol monomethyl ether ሺܥଷܪ଼ܱଶ, ܯ௪ ൌ 76.10ሻ 
50mL Citric acid buffer 
 
Must be made freshly every time 
 
d. 20% p-dimetylamino benzaldehyde (p-DABA): 
20g p-DABA (ܥଽܪଵଵܱܰ,ܯௐ ൌ 149,19) (p-DABA,  
Sigma art no. 156477-100G) 
60mL Ethylene glycol monomethyl ether (VWR art no. 8.00857.1000) 
 
Heat in 60°C water bath to dissolve, followed by a dilution with dH2O to a total 
volume of 100mL.  Cover with parafilm.  Important: p-DABA precipitates 
when Ethylene glycol monomethyl ether cools or evaporates to a certain 
degree. 
 
Must be made freshly every time 
 
e. Stock hydroxyproline standard (0.1µg/µL, 250mL): 
Solve 25mg Hydroxyproline in 250mL 10ିଷN HCl (1N HCl diluted 1:1000) 
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Standards: 
0µg/500µL test sample: 4000µL dH2O 
0.25µg/500µL test sample:  20µL stock + 3980µL dH2O 
0.50µg/500µL test sample:  40µL stock + 3960µL dH2O 
0.75µg/500µL test sample:  60µL stock + 3940µL dH2O 
1.00µg/500µL test sample:  80µL stock + 3920µL dH2O 
1.50µg/500µL test sample:  120µL stock + 3880µL dH2O 
2.00µg/500µL test sample:  160µL stock + 3840µL dH2O 
 
3. Analysis 
All reagents should be room tempered before used in the analysis, with the exception of        
p-DABA that should be kept heated in a water bath until 5 minutes before adding to samples 
(to avoid precipitation).  The analysis is time sensitive, which means that the sample tubes 
should be mixed in the same order and same time interval for every added reagent.  Mix 
samples by gently shaking rack (avoid turning around).  Use Multipipette with a 12.5mL tip to 
add reagents (250µL).  Do not use hard plastic tubes (reacts with hot ethylene glycol), but soft 
plastic tubes (7mL).  Do not use screw tops, but cover with parafilm (especially important 
before samples are put in the water bath).  All samples and standards should be analyzed with 
two parallels. 
Methodological procedure: 
1. 500µL test sample/standard  
2. 250µL Chloramine T 
Mix and leave for 20 minutes in room temperature.  Add thereafter: 
3. 250µL 3.15M Perchloric acid 
Mix and leave for 5 minutes (maximum 8 minutes).  Then add: 
4. 250µL 20% p-DABA 
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Mix and cover all samples with parafilm (colour reaction do not start before 
heated in water bath).  Sample tubes are then put in a heated water bath, 
keeping 60±1°C, for 20 minutes, followed by quick cooling in a sink filled 
with cool water added ice cubes, for 5 minutes. 
Read absorption spectrophotometrically at 557nm (use disposable plastic 
cyvettes) 
The standard curve reflects hydroxyproline concentration in 125µg muscle 
tissue.  Concentration is converted to collagen by multiplying with a factor of 
6.94 (µg collagen/ µg hydroxyproline). 
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4. Hydroxyproline Standard Curves for the Determination of Total 
Collagen Content 
 
Hydroxyproline standard curves using linear regression are shown below for the first (Figure 
A-1) and second (Figure A-2) analytical run:   
 
Figure A-1: Standard curve representing the first series of Hydroxyproline (HYP) analysis.  Y-axis 
represents absorption measured at 557nm in arbitrary units (AU), whereas X-axis represents HYP concentration 
in µg/mL.  Linear correlation coefficient reveals a linear relation (ܴଶ ൌ 0.9981) between absorbency and 
concentrations ranging from 0.0 to 4.0µg HYP/mL.  Y = 1.001x – 6E-05. 
 
  
Figure A-2: Standard curve representing the second series of Hydroxyproline (HYP) analysis.  Y-axis 
represents absorption measured at 557nm in arbitrary units (AU), whereas X-axis represents HYP concentration 
in µg/mL.  Linear correlation coefficient reveals a linear relation (ܴଶ ൌ 0.9981) between absorbency and 
concentrations ranging from 0.0 to 4.0µg HYP/mL.  Y = 1x – 5E-05. 
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Appendix B 
 
Selective Normative Data 
 
Description Normal limits Unit 
Respiration rate  70-150* breaths/min 
Heart rate 300-500* beats/min 
Body temperature 37.5-38.0* °C 
pH (whole blood) 7.40-7.44* AU 
pCO₂ 33-41* mmHg 
pO₂ 91-94* mmHg 
Haemoglobin  15.7* g/dL 
Glucose (fasting, venous) 3.2-5.0** mmol/L 
Hematocrit  0.41-0.51** AU 
Na⁺  137-145** mmol/L 
K⁺  3.6-4.6** mmol/L 
Ca⁺⁺  1.18-1.32** mmol/L 
Cl⁻ 98-106** mmol/L 
Total collagen (muscle) 0.4-4*** g/100g DW 
Total collagen (lungs) 10-20*** g/100g DW 
  
 
Sources: 
* (64) 
** (65) (Note: data representative for humans) 
*** (15)   
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